HCA Reports Second Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
HCA Holdings (HCA) PT Lowered to $92 at Mizuho Securities; Reiterates Buy
July 26, 2017 7:17 AM EDTMizuho Securities lowered its price target on HCA Holdings (NYSE: HCA) to $92.00 (from $98.00) while maintaining a Buy rating. Analyst Sheryl Skolnick still believes that HCA can still preserve margin in 2018, can still grow the top line and can generate around 4% EBITDA... More
HCA Holdings (HCA) Misses Q2 EPS by 6c
July 25, 2017 8:31 AM EDTHCA Holdings (NYSE: HCA) reported Q2 EPS of $1.75, $0.06 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $10.73 billion versus the consensus estimate of $10.85 billion.
Revenues increased 4.0 percent to $10.733 billionNet income attributable to HCA Healthcare, Inc. totaled $657 million, or $1.75 per... More